- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04561388
Electrocochleography Along Cochlear Implant Auditory Rehabilitation (eCochGIC)
Usefulness of Electrocochleography for the Longitudinal Evaluation of Residual Hearing in Hearing Rehabilitation With Cochlear Implant
Electrocochleography (eCochG) is an electrophysiological measurement to evaluate the activity of cochlear hair cells in response to acoustic stimulation. This measure thus reflects the functional state of the cochlea and more specifically the neuronal survival.
Whereas in the normal-hearing subject, eCochG collection requires the introduction of a collection electrode in the middle ear, closest to the cochlea, in the cochlear implant subject, eCochG can be collected through the electrodes of the cochlear implant.
Measured during surgery, eCochGs may help optimize the placement of the electrode array within the cochlea and help in the decision to refer the patient to a conventional cochlear implant or, when residual cochlear activity is detected, to an electro-acoustic implant system.
The main objective of this study is to evaluate the usefulness of intra-operative eCochG collections for the optimization of electrode array placement within the cochlea and then for monitoring the residual hearing and its relationship to hearing performance during the first months of rehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69003
- Hôpital Edouard Herriot
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects, male or female, aged 8 to 75 ;
- Candidates for cochlear implantation with measurable residual hearing?
- French must be the mother tongue and is (or has been) the language of schooling;
- No ototoxic or neurotropic drug treatment (epilepsy, behavioral disorders, other neurological impairment);
- No known cognitive disorders, neurodegenerative disorders (Alzheimer's, Parkinson's, ...), psychiatric pathologies (depression, schizophrenia, eating disorders, ...) or neurodevelopmental disorders (attention deficit disorder with or without hyperactivity, autism spectrum disorder, specific learning disorder);
- Absence of uncorrected visual problems;
- Normal ENT examination;
- Valid membership in a social security system;
- Non-participation in another study;
- Absence of exposure to loud noise in the 72 hours preceding the experiments;
- Written consent to free and informed participation signed by the subject and his/her legal guardians in the case of minors.
Exclusion Criteria:
- Absence of signature of the informed consent by the adult subject and/or the parents of the minor subject ;
- Subjects speaking a foreign language at home and/or whose schooling was conducted in a foreign language (except for subjects attending bilingual schools and one of whose parents' usual language is French);
- Subjects undergoing ototoxic or neurotropic drug treatment (epilepsy, behavioural disorders, other neurological impairment);
- Subjects suffering from cognitive deficits, neurodegenerative disorders (Alzheimer's, Parkinson's, ...), psychiatric pathologies (depression, schizophrenia, eating disorders, ...) or neurodevelopmental disorders (attention deficit disorder with or without hyperactivity, autism spectrum disorder, specific learning disorder);
- General state of health incompatible with the protocols;
- Disability(ies) associated with deafness (deaf-blindness, ...) ;
- Exposure to intense noise in the 72 hours preceding the experiment.
- Non-affiliation to a social security system.
- Pregnant or breastfeeding woman
- Subjects deprived of liberties
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Cochlear implant candidates with measurable residual hearing
Electrocochleography responses to acoustic will be recorded during the cochlear implantation and the 6 first months of use of the cochlear implant. A pure tone audiometry will be done prior and after the implantation. Speech audiometry will be done twice after the cochlear implantation. |
Electrocochleographic responses will be evoked using different pure tone sounds delivered through an insert placed in the external auditory duct. The responses will be recorded with the electrodes of the cochlear implant connected to a dedicated interface. Electrocochleographic responses will be collected continuously during the electrode-array insertion at the implantation surgery using 500Hz pure tone and after suturing with 250, 500, 750 and 1000Hz pure tones. Then, electrocochleographic responses to pure tones from 125 to 8000HZ (according to the subject residual hearing) will be recorded 2 weeks, 1 month, 2 months and 4 months after implantation. The perception thresholds to 125, 250, 500, 750, 1000, 2000, 4000 and 8000 Hz pure tones will be measured within the month preceding the implantation using the same insert t. Pure tone audiometry with the same frequencies will be done 2 weeks, 1, 2 and 4 months after the implantation.
The speech perception will be assessed in silence and in noise in free field 1 and 4 months after implantation.
The speech perception in silence will be assessed using monosyllabic words 60 dB SPL.
Speech in noise will be assessed using an adaptative test with fixed noise level (60 dB SPL).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Electrocochleographic responses
Time Frame: During surgery to 4 month after implantation
|
The amplitudes of electrocochleographic responses (in µV) to the selected acoustic pure tones will be collected.
|
During surgery to 4 month after implantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pure tone thresholds
Time Frame: before implantation, 2 weeks, 1 month, 2 month and 4 month after implantation
|
The perception thresholds (in dB HL) of the selected acoustic pure tones will be collected. No safety issue |
before implantation, 2 weeks, 1 month, 2 month and 4 month after implantation
|
Speech audiometry measurements
Time Frame: 1 month , 4 month
|
For the speech audiometry in silence, the percentage of correct recognition of monosyllabic words' list will be collected. For the speech audiometry in noise, the signal noise ratio(s) (in dB) permitting the subject to reach 50% and/or 70% of speech recognition (SRT50 and SRT70) will be estimated. No safety issue |
1 month , 4 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hung THAI VAN, MD, Hospices Civils de Lyon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 69HCL18_0926
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cochlear Prosthesis Implantation
-
Hospices Civils de LyonCompletedCochlear Prosthesis ImplantationFrance
-
Hospices Civils de LyonNot yet recruitingCochlear Prosthesis ImplantationFrance
-
Centre Hospitalier Universitaire de NiceCompleted
-
Khon Kaen UniversityMinistry of Health, ThailandUnknown
-
Assistance Publique - Hôpitaux de ParisActive, not recruiting
-
University Hospital, ToulouseCentre National de la Recherche Scientifique, FranceCompletedCochlear ImplantationFrance
-
Oticon MedicalCompletedCochlear ImplantationUnited Kingdom
-
Maastricht University Medical CenterAdvanced BionicsUnknownCochlear Implantation | Cone-Beam Computed TomographyNetherlands
-
Charles University, Czech RepublicUniversity Hospital, MotolRecruiting
-
Fundacion para la Investigacion Biomedica del Hospital...RecruitingImplantation of a Reverse Shoulder ProsthesisSpain
Clinical Trials on Electrocochleography
-
Ohio State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, BilateralUnited States
-
Guy's and St Thomas' NHS Foundation TrustUnknownHearing Loss, CochlearUnited Kingdom
-
Medical College of WisconsinActive, not recruitingHearing Loss | Cochlear ImplantUnited States
-
University Hospital, ToulouseNot yet recruitingSuperior Semicircular Canal DehiscenceFrance
-
University Hospital, Clermont-FerrandLaboratory of Neurosensory Biophysics - UMR INSERM 1107.; Foundation of Gueules... and other collaboratorsRecruitingHealthy Volunteer | Without Hearing DisordersFrance
-
Direction Centrale du Service de Santé des ArméesRecruiting